Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026

Viridian Therapeutics (Nasdaq: VRDN) will report third quarter 2026 financial results before the market opens on Wednesday, November 4, 2026. Management will host a live conference call at 8:00 a.m. ET the same day to discuss results and provide a business update, with a webcast available on the company's investor relations site. The release contains no financial figures; it is a routine earnings-date notice.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.